Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.

Author: BirgeStanley J, OlsenMargaret A, SchootmanMario, StropeSeth A, VouriScott Martin

Paper Details 
Original Abstract of the Article :
BACKGROUND: Oral oxybutynin has been associated with the development of cognitive impairment. OBJECTIVE: The objective of this study was to describe the use of oral oxybutynin versus other antimuscarinics (e.g., tolterodine, darifenacin, solifenacin, trospium, fesoterodine, transdermal oxybutynin) ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/29492862

データ提供:米国国立医学図書館(NLM)

Antimuscarinic Agents in Older Adults: Navigating the Sands of Cognitive Impairment

As our population ages, the need for effective and safe medication management becomes increasingly critical. This study investigates the prescribing practices of antimuscarinic agents, a class of drugs used to treat urinary incontinence, in older adults with cognitive impairment. The study highlights the potential risks associated with oral oxybutynin, a specific antimuscarinic, and explores the use of alternative medications. The researchers identified a concerning trend in the increased use of oral oxybutynin despite its association with cognitive decline. This study raises important questions about prescribing practices and the need for careful consideration of medication choices for vulnerable populations.

A Navigational Guide for Antimuscarinic Prescribing: Seeking Safe Passage

This study emphasizes the need for careful medication selection in older adults, especially those with cognitive impairment. The researchers found that patients with cognitive impairment were less likely to be prescribed oral oxybutynin, suggesting a growing awareness of its potential risks. The study highlights the importance of considering individual patient factors, including cognitive function, when prescribing medications, ensuring that treatment choices are safe and effective.

From Sand Dunes to Better Care: Finding the Right Path

This research serves as a reminder that the journey through aging involves navigating a complex landscape of medication choices and potential side effects. By understanding the nuances of antimuscarinic prescribing in older adults, clinicians can guide their patients towards safer and more effective treatment options. This research underscores the importance of ongoing dialogue and collaboration between clinicians and patients to ensure safe and effective medication management throughout the aging process.

Dr. Camel's Conclusion

The study's findings highlight the need for a personalized approach to medication management in older adults, like a camel carefully choosing its path through the desert. By understanding the potential risks and benefits of different medications, clinicians can ensure that older adults receive the most appropriate care, maximizing their well-being and quality of life.
Date :
  1. Date Completed 2018-08-13
  2. Date Revised 2019-04-01
Further Info :

Pubmed ID

29492862

DOI: Digital Object Identifier

NIHMS947120

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.